<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Glaxosmithkline Plc</title><link href="http://liverdiseaseinfo.com/topic/glaxosmithkline-plc" rel="alternate"></link><id>http://liverdiseaseinfo.com/topic/glaxosmithkline-plc</id><updated>2010-04-16T10:40:23Z</updated><entry><title>U.S. probes Roche, Glaxo diet drug over liver injury</title><link href="http://liverdiseaseinfo.com/liver-diseases/probes-roche-glaxo-diet-drug-liver-injury-643067a" rel="alternate"></link><updated>2010-04-16T10:40:21Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/probes-roche-glaxo-diet-drug-liver-injury-643067a/</id><summary type="html">&lt;div&gt;&lt;p&gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - U.S. health officials are reviewing reports of liver injury in people who took &lt;a title="F. Hoffman-La Roche Ltd." href="/topic/F.+Hoffman-La+Roche+Ltd." &gt;Roche Holding AG&lt;/a&gt;'s weight loss drug &lt;a title="Xenical" href="/topic/Xenical" &gt;Xenical&lt;/a&gt; or the over-the-counter version sold by &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The &lt;a title="Food an...</summary><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="United States"></category><category term="Food and Drug Administration"></category><category term="GlaxoSmithKline plc"></category><category term="Xenical"></category><category term="Reuters Group plc"></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Lisa Richwine"></category><category term="Ransdell Pierson"></category><category term="Krensavage Asset Management LLC"></category><category term="New York Stock Exchange"></category></entry><entry><title>FDA probes liver damage with weight loss pill alli</title><link href="http://liverdiseaseinfo.com/liver-diseases/fda-probes-liver-damage-weight-loss-pill-alli-643037a" rel="alternate"></link><updated>2010-04-16T10:40:23Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-16:/liver-diseases/fda-probes-liver-damage-weight-loss-pill-alli-643037a/</id><summary type="html">&lt;div id="subtitle"&gt;FDA probes liver damage with alli, only nonprescription weight loss drug approved in US&lt;/div&gt;&lt;div&gt;&lt;p&gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.&lt;/p&gt;&lt;p&gt;Regulators said Monday they have received more than 30 reports of liver damage in patients taking alli and &lt;a title="Xeni...</summary><category term="Weight Loss"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="GlaxoSmithKline plc"></category><category term="Western Europe"></category><category term="Vioxx"></category><category term="Xenical"></category><category term="London (England)"></category><category term="Debbie Bolding"></category></entry><entry><title>BRITAIN GLAXOSMITHKLINE</title><link href="http://liverdiseaseinfo.com/photo/britain-glaxosmithkline-478995p" rel="alternate"></link><updated>2010-04-15T03:13:25Z</updated><author><name>AP News</name></author><id>tag:liverdiseaseinfo.com,2010-04-15:/photo/britain-glaxosmithkline-478995p/</id><summary type="html">A sign for British pharmaceuticals firm &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt; is seen on its offices, in &lt;a title="London (England)" href="/topic/London+(England)" &gt;London&lt;/a&gt;, Monday, April 20, 2009. British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business &lt;a title="Stiefel Laboratories Inc." href="/topic/Stiefel+Laboratories+Inc." &gt;Stiefel Laboratories Inc.&lt;/a&gt; GlaxoSmithKline will also assu...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="GlaxoSmithKline plc"></category><category term="Western Europe"></category><category term="Stiefel Laboratories Inc."></category><category term="Skin Health"></category><category term="London (England)"></category></entry></feed>
